FR1039M - Ribonuclease-based medicine for the treatment of psoriasis and other dermatoses. - Google Patents

Ribonuclease-based medicine for the treatment of psoriasis and other dermatoses.

Info

Publication number
FR1039M
FR1039M FR857637A FR857637A FR1039M FR 1039 M FR1039 M FR 1039M FR 857637 A FR857637 A FR 857637A FR 857637 A FR857637 A FR 857637A FR 1039 M FR1039 M FR 1039M
Authority
FR
France
Prior art keywords
dermatoses
ribonuclease
psoriasis
treatment
based medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR857637A
Other languages
French (fr)
Inventor
Max Joseph Pierre Adrien Tetau
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MAX JOSEPH PIERRE
Original Assignee
MAX JOSEPH PIERRE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MAX JOSEPH PIERRE filed Critical MAX JOSEPH PIERRE
Priority to FR857637A priority Critical patent/FR1039M/en
Application granted granted Critical
Publication of FR1039M publication Critical patent/FR1039M/en
Active legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
FR857637A 1961-04-04 1961-04-04 Ribonuclease-based medicine for the treatment of psoriasis and other dermatoses. Active FR1039M (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR857637A FR1039M (en) 1961-04-04 1961-04-04 Ribonuclease-based medicine for the treatment of psoriasis and other dermatoses.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR857637A FR1039M (en) 1961-04-04 1961-04-04 Ribonuclease-based medicine for the treatment of psoriasis and other dermatoses.

Publications (1)

Publication Number Publication Date
FR1039M true FR1039M (en) 1962-01-02

Family

ID=88196248

Family Applications (1)

Application Number Title Priority Date Filing Date
FR857637A Active FR1039M (en) 1961-04-04 1961-04-04 Ribonuclease-based medicine for the treatment of psoriasis and other dermatoses.

Country Status (1)

Country Link
FR (1) FR1039M (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1051142A1 (en) * 1997-10-16 2000-11-15 Deguang Zhu A new powerful cosmetic or pharmaceutical composition

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1051142A1 (en) * 1997-10-16 2000-11-15 Deguang Zhu A new powerful cosmetic or pharmaceutical composition
EP1051142A4 (en) * 1997-10-16 2002-01-30 Deguang Zhu A new powerful cosmetic or pharmaceutical composition

Similar Documents

Publication Publication Date Title
FR1444M (en) New drug especially for the treatment of ovarian irregularities and insufficiencies.
FR1137M (en) Therapeutic applications of cyclohexyl-phenols.
FR2944M (en) Medicine for the treatment of cough based on 2-amino-6-methylheptane.
FR1438M (en) New drug effective in the treatment of atherosclerosis.
FR1039M (en) Ribonuclease-based medicine for the treatment of psoriasis and other dermatoses.
FR2193M (en) New drug for the treatment of infectious diseases.
FR3395M (en) New drug, in particular for the treatment of neurodepressive states and anxiety psychoses.
BE630069A (en) Therapeutic composition for the treatment of parkinsonism.
FR151M (en) New drug, in particular for the treatment of neuro-depressive states and anxiety psychoses.
FR1456M (en) New drug in particular for the treatment of deficiencies of the corpus luteum.
FR1830M (en) New drug in particular for the treatment of follicle-stimulating hyperactivity.
FR1224M (en) Homeoflora treatment of the sebaceous glands.
FR1143M (en) Medicinal product based on a pyimidic derivative, in particular for the treatment of hypercholesterolemia and hyper-uricemia.
FR2458M (en) New drug in particular for the treatment of depressive states or anxiety.
FR1510M (en) New drug in particular for the treatment of deficiencies of the corpus luteum.
FR1174321A (en) Sewage treatment
FR1223M (en) Homeoflora decongestant treatment of the heart.
FR1122M (en) New drug in particular for the treatment of hypercholesterolemia.
FR1596M (en) Drug for the treatment of alcoholism.
FR1418M (en) New drug for the treatment of coronary artery spasms.
FR1141M (en) New drug in particular for the treatment of spasms of coronary origin.
FR1635M (en) New drug in particular for the treatment of spasms of coronary origin.
FR1284M (en) Medicinal product for the treatment of primary hypogonadotrophic amenorrhea and related conditions.
FR1466M (en) New drug in particular for the treatment of arterial hypertension.
FR1512M (en) New drug in particular for the treatment of arterial hypertension.